Therapeutic frameworks in integration sessions in substance‐assisted psychotherapy: A systematised review
Open Access
- 26 December 2023
- journal article
- review article
- Published by Wiley in Clinical Psychology & Psychotherapy
- Vol. 31 (1)
Abstract
Serotonergic psychedelics and related substances have been explored as potential adjuncts in substance‐assisted psychotherapy (SAPT) for treating various disorders. SAPT can be divided into three phases: preparation, administration and integration. Integration is commonly defined as the comprehension and effective application of insights from psychedelic experiences into everyday life. However, there is limited research regarding the most appropriate therapeutic approach during SAPT. In this article, we discuss the current evidence for different therapeutic frameworks for integration sessions when serotonergic psychedelics and entactogens are used as adjuncts to psychotherapy. We conducted a systematised review of the literature following PRISMA guidelines and searched PsycINFO, MEDLINE and Cochrane Library databases. The final synthesis included 75 clinical trials, mixed‐methods investigations, treatment manuals, study protocols, quasi‐experiments, qualitative investigations, descriptive studies, opinion papers, reviews, books and book chapters, published until 11 November 2022. The effects that various therapeutic approaches for integration sessions have on therapeutic outcomes have not been investigated by means of rigorous research. Most of the available evidence we retrieved was not supported by empirical data, thus limiting any conclusive statements regarding appropriate therapeutic frameworks for integration sessions for SAPT. Current clinical studies have used a range of therapeutic frameworks with the majority drawing from the humanistic–experiential tradition. While integration is regarded as crucial for the safe application of SAPT, there is currently an insufficient evidence base to suggest that any type of therapy is effective for guiding integration sessions. A systematic investigation of different therapeutic frameworks for integration and additional therapy‐related factors is needed.Keywords
This publication has 135 references indexed in Scilit:
- A randomized, controlled pilot study of MDMA (±3,4-Methylenedioxymethamphetamine)-assisted psychotherapy for treatment of resistant, chronic Post-Traumatic Stress Disorder (PTSD)Journal of Psychopharmacology, 2012
- The Efficacy of Cognitive Behavioral Therapy: A Review of Meta-analysesCognitive Therapy and Research, 2012
- Therapeutic Alliance and Outcome of Psychotherapy: Historical Excursus, Measurements, and Prospects for ResearchFrontiers in Psychology, 2011
- ExpectationsJournal of Clinical Psychology, 2010
- The safety and efficacy of ±3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot studyJournal of Psychopharmacology, 2010
- MDMA-Assisted Psychotherapy Using Low Doses in a Small Sample of Women with Chronic Posttraumatic Stress DisorderJournal of Psychoactive Drugs, 2008
- Human hallucinogen research: guidelines for safetyJournal of Psychopharmacology, 2008
- Supportive–expressive group therapy for primary breast cancer patients: a randomized prospective multicenter trialPsycho-Oncology, 2007
- A Method of Conducting Therapeutic Sessions with MDMAJournal of Psychoactive Drugs, 1998
- Set, Setting, and MatrixJournal of Psychoactive Drugs, 1997